DIA 48th Annual Meeting
Click here to go to the previous page
New Ways to Learn What Happens to Patients AFTER Approval
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 109
Date: Monday, June 25, 2012
Time: 10:00 AM to 11:30 AM  EST
 Stephen Raymond, PHT Corporation, United States
Donald Manning, Adynxx, Inc., United States
 Chad Gwaltney, PRO Consulting, United States
 Melissa Robb, FDA, United States
This session explores new ways to help physicians monitor and support individual patients for whom they prescribe medications. A physician will present on the topic, and the chair is seeking discussion from attendees with medical experience.

Learning Objectives:
Discuss shortcomings of pharmacovigilance, the limitations of tracking SAE's, REMS, and postmarket clinical research
Assess technologies and new ways to obtain information about a patient, and ways for physicians to support patient who use approved medications in the real world.